WEDNESDAY, May 21 (HealthDay News) -- At least some of the biological risk for childhood asthma and allergies traces back to the womb, new research suggests.
Both the order of birth and even the way a baby is delivered have a significant impact on the long-term strength of a child's allergic defenses, scientists say.
The findings were presented Wednesday during the American Thoracic Society's International Conference, in Toronto.
At the meeting, one team of scientists said it had evidence indicating that when a specific genetic marker for allergic and asthmatic development is present among a first-born child, it appears to raise the risk for allergic conditions as far as 10 years down the road. However, when the exact same marker is present in a family's second or third child, the gene seems to have exactly the opposite effect -- actually lowering such risk.
"This is the first time it has been demonstrated that birth order can affect the behavior of genes related to asthma and allergies, and that birth order can therefore affect the risk for developing one or the other," said study author Dr. Wilfried Karmaus, a professor in the department of epidemiology and biostatistics at the University of South Carolina in Columbia.
On a second front, another team of researchers suggested that regulatory cells associated with proper immune function may be impaired in babies delivered by Caesarean section.
"We found a dysfunctional cellular response in the normally protective immune system among C-section babies," observed Dr. Ngoc Ly, an assistant professor of pediatrics at the University of California at San Francisco. "And although more work needs to be done to follow how long this response might endure, we think this disrupted immune pathway may influence the development of asthma later on."
To explore the relationship between birth order and asthma/allergy risk, Karmaus and his team tracked more than 1,200 newborns from Great Britain's Isle of Wight.
After recording birth orders, the researchers tested each newborns allergic status by examining indicators present in umbilical cord blood. As well, they conducted standard skin prick allergy tests at both age 4 and age 10.
The authors found that among firstborn children, the presence of a particular gene strain -- known as the IL-13 gene variant -- was associated with a higher risk for having an "allergic response." This link continued to persist a decade later.
By contrast, among second or later-born children no such association between IL-13 and higher risk was found. In fact, the role of IL-13 seemed to "switch over" to that of a risk protector.
"The fetus is, in effect, a foreign body," noted Karmaus. "And a foreign body can be exposed to a lot of immune arousal or not, depending. So we think that something during pregnancy -- probably the immune system of the mother -- stimulates the IL-13 gene to act differently, depending on birth order. We haven't shown how this works yet, but that's the idea."
Karmaus suggested that the finding could theoretically lead to the crafting of interventions -- perhaps therapeutic, perhaps simply lifestyle changes -- which could reduce the allergic response risk for firstborns.